228 related articles for article (PubMed ID: 18339885)
1. Dietary genistein inhibits metastasis of human prostate cancer in mice.
Lakshman M; Xu L; Ananthanarayanan V; Cooper J; Takimoto CH; Helenowski I; Pelling JC; Bergan RC
Cancer Res; 2008 Mar; 68(6):2024-32. PubMed ID: 18339885
[TBL] [Abstract][Full Text] [Related]
2. Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway.
Xu L; Bergan RC
Mol Pharmacol; 2006 Sep; 70(3):869-77. PubMed ID: 16772519
[TBL] [Abstract][Full Text] [Related]
3. Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells.
Huang X; Chen S; Xu L; Liu Y; Deb DK; Platanias LC; Bergan RC
Cancer Res; 2005 Apr; 65(8):3470-8. PubMed ID: 15833883
[TBL] [Abstract][Full Text] [Related]
4. Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model.
Vantyghem SA; Wilson SM; Postenka CO; Al-Katib W; Tuck AB; Chambers AF
Cancer Res; 2005 Apr; 65(8):3396-403. PubMed ID: 15833874
[TBL] [Abstract][Full Text] [Related]
5. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M
Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258
[TBL] [Abstract][Full Text] [Related]
6. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
Chang HL; Wu YC; Su JH; Yeh YT; Yuan SS
J Pharmacol Exp Ther; 2008 Jun; 325(3):841-9. PubMed ID: 18337475
[TBL] [Abstract][Full Text] [Related]
7. Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway.
Zhu H; Liu XW; Cai TY; Cao J; Tu CX; Lu W; He QJ; Yang B
J Pharmacol Exp Ther; 2010 Aug; 334(2):489-99. PubMed ID: 20472666
[TBL] [Abstract][Full Text] [Related]
8. Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity.
Zoubeidi A; Zardan A; Beraldi E; Fazli L; Sowery R; Rennie P; Nelson C; Gleave M
Cancer Res; 2007 Nov; 67(21):10455-65. PubMed ID: 17974989
[TBL] [Abstract][Full Text] [Related]
9. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
[TBL] [Abstract][Full Text] [Related]
10. Tranilast inhibits the growth and metastasis of mammary carcinoma.
Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
[TBL] [Abstract][Full Text] [Related]
11. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.
Xu L; Chen S; Bergan RC
Oncogene; 2006 May; 25(21):2987-98. PubMed ID: 16407830
[TBL] [Abstract][Full Text] [Related]
12. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
13. Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells.
Jin CY; Park C; Kim GY; Lee SJ; Kim WJ; Choi YH
Chem Biol Interact; 2009 Jul; 180(2):143-50. PubMed ID: 19497411
[TBL] [Abstract][Full Text] [Related]
14. Orthotopically implanted SCID mouse model of human lung cancer suitable for investigating metastatic potential and anticancer drug effects.
Kondo K; Fujino H; Miyoshi T; Ishikura H; Sakiyama S; Monden Y
Oncol Rep; 2004 Nov; 12(5):991-9. PubMed ID: 15492783
[TBL] [Abstract][Full Text] [Related]
15. Noscapine inhibits human prostate cancer progression and metastasis in a mouse model.
Barken I; Geller J; Rogosnitzky M
Anticancer Res; 2008; 28(6A):3701-4. PubMed ID: 19189652
[TBL] [Abstract][Full Text] [Related]
16. Garlic-derived S-allylmercaptocysteine is a novel in vivo antimetastatic agent for androgen-independent prostate cancer.
Howard EW; Ling MT; Chua CW; Cheung HW; Wang X; Wong YC
Clin Cancer Res; 2007 Mar; 13(6):1847-56. PubMed ID: 17363541
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model.
Wang Y; Raffoul JJ; Che M; Doerge DR; Joiner MC; Kucuk O; Sarkar FH; Hillman GG
Radiat Res; 2006 Jul; 166(1 Pt 1):73-80. PubMed ID: 16808622
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide.
Papo N; Seger D; Makovitzki A; Kalchenko V; Eshhar Z; Degani H; Shai Y
Cancer Res; 2006 May; 66(10):5371-8. PubMed ID: 16707464
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549.
Liu G; Meng X; Jin Y; Bai J; Zhao Y; Cui X; Chen F; Fu S
Cell Biol Int; 2008 Jun; 32(6):663-70. PubMed ID: 18343694
[TBL] [Abstract][Full Text] [Related]
20. The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.
Miwa S; Mizokami A; Keller ET; Taichman R; Zhang J; Namiki M
Cancer Res; 2005 Oct; 65(19):8818-25. PubMed ID: 16204052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
